• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向肺癌中的代谢瓶颈

Targeting Metabolic Bottlenecks in Lung Cancer.

作者信息

Sayin Volkan I, LeBoeuf Sarah E, Papagiannakopoulos Thales

机构信息

Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, SE-405 30 Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden.

Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA; Perlmutter Cancer Center, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.

出版信息

Trends Cancer. 2019 Aug;5(8):457-459. doi: 10.1016/j.trecan.2019.06.001. Epub 2019 Jun 27.

DOI:10.1016/j.trecan.2019.06.001
PMID:31421901
Abstract

Lung cancer remains one of the most genetically complex, aggressive, and lethal solid malignancies. Understanding how distinct lung cancer mutations give rise to altered nutrient requirements and promote immune evasion in the context of a heterogeneous lung tumor microenvironment is vital for the development of novel personalized therapeutic strategies.

摘要

肺癌仍然是遗传复杂性最高、侵袭性最强且致死性最高的实体恶性肿瘤之一。了解不同的肺癌突变如何在异质性肺肿瘤微环境中导致营养需求改变并促进免疫逃逸,对于开发新型个性化治疗策略至关重要。

相似文献

1
Targeting Metabolic Bottlenecks in Lung Cancer.靶向肺癌中的代谢瓶颈
Trends Cancer. 2019 Aug;5(8):457-459. doi: 10.1016/j.trecan.2019.06.001. Epub 2019 Jun 27.
2
Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes.肺腺癌单细胞 RNA 测序揭示免疫反应相关基因的异质性。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.121387.
3
The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.抗 PD-1/PD-L1 免疫疗法在 KRAS 突变型非小细胞肺癌中的优越疗效与炎症表型和增加的免疫原性相关。
Cancer Lett. 2020 Feb 1;470:95-105. doi: 10.1016/j.canlet.2019.10.027. Epub 2019 Oct 20.
4
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy.调节肿瘤微环境:STK11 的免疫特性综述及其在非小细胞肺癌免疫治疗中的预测与预后作用。
Curr Treat Options Oncol. 2021 Sep 15;22(11):96. doi: 10.1007/s11864-021-00891-8.
5
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.- 突变与 PD-1 抑制剂耐药在 - 突变型肺腺癌中的研究进展
Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.
6
Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma.肺腺癌患者的联合免疫分层与治疗靶点鉴定。
Aging (Albany NY). 2020 Aug 27;12(16):16514-16538. doi: 10.18632/aging.103775.
7
Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis.免疫亚组分析可能是评估非小细胞肺癌治疗效果和预后的一个较好选择。
Aging (Albany NY). 2021 May 11;13(9):12691-12709. doi: 10.18632/aging.202941.
8
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer.谷氨酰胺酶抑制可损害 STK11-/Lkb1 缺陷型肺癌中的 CD8 T 细胞激活。
Cell Metab. 2022 Jun 7;34(6):874-887.e6. doi: 10.1016/j.cmet.2022.04.003. Epub 2022 May 2.
9
[Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].基于TCGA数据库的EGFR突变型与EGFR野生型肺腺癌患者免疫微环境比较研究
Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):236-244. doi: 10.3779/j.issn.1009-3419.2021.102.15.
10
Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer.阐明非小细胞肺癌中 MET 蛋白表达和基因拷贝数状态与 PD-L1 表达和免疫微环境的关系。
Lung Cancer. 2020 Mar;141:21-31. doi: 10.1016/j.lungcan.2020.01.005. Epub 2020 Jan 7.

引用本文的文献

1
In vivo functional screens reveal loss as a driver of chemoresistance in small cell lung cancer.体内功能筛选揭示缺失是小细胞肺癌化疗耐药的驱动因素。
Sci Adv. 2025 Apr 25;11(17):eadq7084. doi: 10.1126/sciadv.adq7084. Epub 2025 Apr 23.
2
Procyanidin B1 Promotes PSMC3-NRF2 Ubiquitination to Induce Ferroptosis in Glioblastoma.原花青素B1促进PSMC3-NRF2泛素化以诱导胶质母细胞瘤中的铁死亡。
Phytother Res. 2024 Dec;38(12):5583-5597. doi: 10.1002/ptr.8328. Epub 2024 Sep 18.
3
Uncovering Porphyrin Accumulation in the Tumor Microenvironment.
揭示肿瘤微环境中的卟啉积累。
Genes (Basel). 2024 Jul 22;15(7):961. doi: 10.3390/genes15070961.
4
Acquired Radiation Resistance Induces Thiol-dependent Cisplatin Cross-resistance.获得性辐射抗性诱导硫醇依赖性顺铂交叉抗性。
Radiat Res. 2024 Feb 1;201(2):174-187. doi: 10.1667/RADE-23-00005.1.
5
Pirfenidone inhibits TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancer.吡非尼酮抑制非小细胞肺癌上皮-间充质转化过程中 TGF-β1 诱导的代谢重编程。
J Cell Mol Med. 2024 Feb;28(3):e18059. doi: 10.1111/jcmm.18059. Epub 2023 Dec 23.
6
Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management.动脉粥样硬化、糖尿病和癌症:共同的流行病学、共同的机制和未来的管理。
Int J Mol Sci. 2023 Jul 22;24(14):11786. doi: 10.3390/ijms241411786.
7
Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma.肺腺癌中脂肪酸代谢的特征分析
Front Genet. 2022 Jul 14;13:905508. doi: 10.3389/fgene.2022.905508. eCollection 2022.
8
LncRNA LASTR promote lung cancer progression through the miR-137/TGFA/PI3K/AKT axis through integration analysis.通过整合分析,长链非编码RNA LASTR通过miR-137/TGFA/PI3K/AKT轴促进肺癌进展。
J Cancer. 2022 Jan 6;13(4):1086-1096. doi: 10.7150/jca.66067. eCollection 2022.
9
Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma.铁蛋白轻链的转录抑制增加肺腺癌对铁死亡的敏感性。
Front Cell Dev Biol. 2021 Oct 26;9:719187. doi: 10.3389/fcell.2021.719187. eCollection 2021.
10
Cancer metabolism: looking forward.癌症代谢:展望未来。
Nat Rev Cancer. 2021 Oct;21(10):669-680. doi: 10.1038/s41568-021-00378-6. Epub 2021 Jul 16.